These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 36644850)

  • 1. Re-envisioning the design of nanomedicines: harnessing automation and artificial intelligence.
    Zaslavsky J; Bannigan P; Allen C
    Expert Opin Drug Deliv; 2023 Feb; 20(2):241-257. PubMed ID: 36644850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Self-driving laboratories: A paradigm shift in nanomedicine development.
    Hickman RJ; Bannigan P; Bao Z; Aspuru-Guzik A; Allen C
    Matter; 2023 Apr; 6(4):1071-1081. PubMed ID: 37020832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Artificial intelligence aids in development of nanomedicines for cancer management.
    Tan P; Chen X; Zhang H; Wei Q; Luo K
    Semin Cancer Biol; 2023 Feb; 89():61-75. PubMed ID: 36682438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Artificial intelligence to bring nanomedicine to life.
    Serov N; Vinogradov V
    Adv Drug Deliv Rev; 2022 May; 184():114194. PubMed ID: 35283223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Artificial Intelligence and Machine Learning in Computational Nanotoxicology: Unlocking and Empowering Nanomedicine.
    Singh AV; Ansari MHD; Rosenkranz D; Maharjan RS; Kriegel FL; Gandhi K; Kanase A; Singh R; Laux P; Luch A
    Adv Healthc Mater; 2020 Sep; 9(17):e1901862. PubMed ID: 32627972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrating Artificial and Human Intelligence: A Partnership for Responsible Innovation in Biomedical Engineering and Medicine.
    Dzobo K; Adotey S; Thomford NE; Dzobo W
    OMICS; 2020 May; 24(5):247-263. PubMed ID: 31313972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanomedicine Ex Machina: Between Model-Informed Development and Artificial Intelligence.
    Villa Nova M; Lin TP; Shanehsazzadeh S; Jain K; Ng SCY; Wacker R; Chichakly K; Wacker MG
    Front Digit Health; 2022; 4():799341. PubMed ID: 35252958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Knowledge Gaps in Generating Cell-Based Drug Delivery Systems and a Possible Meeting with Artificial Intelligence.
    Mozafari N; Mozafari N; Dehshahri A; Azadi A
    Mol Pharm; 2023 Aug; 20(8):3757-3778. PubMed ID: 37428824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What place for intelligent automation and artificial intelligence to preserve and strengthen vigilance expertise in the face of increasing declarations?
    Pariente A; Micallef J; Lahouegue A; Molimard M; Auffret M; Chouchana L; Denis B; Faillie JL; Grandvuillemin A; Letinier L; Pierron E; Pons C; Pujade I; Rubino H; Salvo F
    Therapie; 2023; 78(1):131-143. PubMed ID: 36572627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Artificial Intelligence for Autonomous Molecular Design: A Perspective.
    Joshi RP; Kumar N
    Molecules; 2021 Nov; 26(22):. PubMed ID: 34833853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enabling AI in synthetic biology through Construction File specification.
    Ataii N; Bakshi S; Chen Y; Fernandez M; Shao Z; Scheftel Z; Tou C; Vega M; Wang Y; Zhang H; Zhao Z; Anderson JC
    PLoS One; 2023; 18(11):e0294469. PubMed ID: 37956196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Automation, machine learning, and artificial intelligence in echocardiography: A brave new world.
    Gandhi S; Mosleh W; Shen J; Chow CM
    Echocardiography; 2018 Sep; 35(9):1402-1418. PubMed ID: 29974498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Applying artificial intelligence and computational modeling to nanomedicine.
    Hamilton S; Kingston BR
    Curr Opin Biotechnol; 2024 Feb; 85():103043. PubMed ID: 38091874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Artificial intelligence and machine learning approaches for drug design: challenges and opportunities for the pharmaceutical industries.
    Selvaraj C; Chandra I; Singh SK
    Mol Divers; 2022 Jun; 26(3):1893-1913. PubMed ID: 34686947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Addressing the challenges to increase the efficiency of translating nanomedicine formulations to patients.
    Bhattacharjee S; Brayden DJ
    Expert Opin Drug Discov; 2021 Mar; 16(3):235-254. PubMed ID: 33108229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanomedicine-based commercial formulations: current developments and future prospects.
    Thapa RK; Kim JO
    J Pharm Investig; 2023; 53(1):19-33. PubMed ID: 36568502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multi-Omics and Artificial Intelligence-Guided Drug Repositioning: Prospects, Challenges, and Lessons Learned from COVID-19.
    Cong Y; Endo T
    OMICS; 2022 Jul; 26(7):361-371. PubMed ID: 35759424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Automation and artificial intelligence in radiation therapy treatment planning.
    Jones S; Thompson K; Porter B; Shepherd M; Sapkaroski D; Grimshaw A; Hargrave C
    J Med Radiat Sci; 2024 Jun; 71(2):290-298. PubMed ID: 37794690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Teaching, Learning and Assessing Anatomy with Artificial Intelligence: The Road to a Better Future.
    Abdellatif H; Al Mushaiqri M; Albalushi H; Al-Zaabi AA; Roychoudhury S; Das S
    Int J Environ Res Public Health; 2022 Oct; 19(21):. PubMed ID: 36361089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Comprehensive Study of Artificial Intelligence and Machine Learning Approaches in Confronting the Coronavirus (COVID-19) Pandemic.
    Rahman MM; Khatun F; Uzzaman A; Sami SI; Bhuiyan MA; Kiong TS
    Int J Health Serv; 2021 Oct; 51(4):446-461. PubMed ID: 33999732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.